scholarly article | Q13442814 |
P2093 | author name string | J Y Lee | |
R C Fuhlbrigge | |||
S Rafii | |||
R Sackstein | |||
C J Dimitroff | |||
P2860 | cites work | The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor | Q24306681 |
The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells | Q24317501 | ||
L-selectin from human, but not from mouse neutrophils binds directly to E-selectin | Q24681588 | ||
A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity | Q28140610 | ||
CD44 is the principal cell surface receptor for hyaluronate | Q28261336 | ||
Detection of an L-selectin ligand on a hematopoietic progenitor cell line | Q28286964 | ||
Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells | Q34444540 | ||
A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells | Q35578307 | ||
A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites | Q35811240 | ||
The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1 | Q36230719 | ||
Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan | Q36254851 | ||
CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway | Q36365827 | ||
Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. | Q36401478 | ||
Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow | Q36735787 | ||
The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. | Q38333447 | ||
E-selectin and very late activation antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endothelium | Q40847238 | ||
The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow | Q40857641 | ||
Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes | Q40956675 | ||
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics | Q41153338 | ||
Selectins and their ligands: current concepts and controversies. | Q41192497 | ||
Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). | Q41335370 | ||
The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins | Q41346155 | ||
ELAM-1 is an adhesion molecule for skin-homing T cells | Q41694765 | ||
Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans | Q41861545 | ||
A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. | Q42812808 | ||
Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. | Q42827719 | ||
Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development | Q45864464 | ||
CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. | Q52192639 | ||
The glycoprotease of Pasteurella haemolytica A1 eliminates binding of myeloid cells to P-selectin but not to E-selectin | Q67464443 | ||
An antibody that facilitates hematopoietic engraftment recognizes CD44 | Q68530717 | ||
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion | Q71630732 | ||
Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding | Q71631203 | ||
L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes: interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity | Q71727831 | ||
Requirement for CD44 in proliferation and homing of hematopoietic precursor cells | Q71802258 | ||
The E-selectin ligand-1 is selectively activated in Chinese hamster ovary cells by the alpha(1,3)-fucosyltransferases IV and VII | Q71860072 | ||
PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis | Q73065694 | ||
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin | Q73254075 | ||
Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels | Q73998199 | ||
Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation | Q74046838 | ||
Treatment of mice with anti-CD44 after allogeneic bone marrow cell transplantation is lethal | Q74191514 | ||
Adhesion of hematopoietic progenitor cells to human bone marrow or umbilical vein derived endothelial cell lines: a comparison | Q78068396 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1277-86 | |
P577 | publication date | 2001-06-11 | |
P1433 | published in | Journal of Cell Biology | Q1524550 |
P1476 | title | CD44 is a major E-selectin ligand on human hematopoietic progenitor cells | |
P478 | volume | 153 |
Q47339131 | A mouse model to study organ homing behaviour of haemopoietic progenitor cells reveals high selectivity but low efficiency of multipotent progenitors to home into haemopoietic organs |
Q98466643 | Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches |
Q36875875 | Adhesion molecules in cutaneous immunity |
Q38614733 | Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment |
Q30491779 | Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. |
Q29994863 | An Analysis of Trafficking Receptors Shows that CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells |
Q35172452 | Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells |
Q36951900 | Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin |
Q38936714 | Biological roles of glycans |
Q27302171 | Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci |
Q38210630 | Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target |
Q39431970 | Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment |
Q37094051 | Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang |
Q93112223 | Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis |
Q42742267 | CD43 is a ligand for E-selectin on CLA+ human T cells |
Q35376738 | CD44 and HCELL: preventing hematogenous metastasis at step 1. |
Q48029838 | CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury |
Q36403511 | CD44 is a physiological E-selectin ligand on neutrophils |
Q28250164 | CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions |
Q38935394 | CD44 variant, but not standard CD44 isoforms, mediate disassembly of endothelial VE-cadherin junction on metastatic melanoma cells |
Q91631004 | Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer |
Q36251782 | Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis |
Q38288595 | Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology. |
Q27334142 | Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow |
Q30582616 | Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44 |
Q30558855 | Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice |
Q33927218 | Core 1-derived O-glycans are essential E-selectin ligands on neutrophils |
Q47875896 | Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy |
Q42917963 | Directing Stem Cell Trafficking via GPS |
Q50197234 | E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy |
Q48397159 | E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases |
Q39594713 | E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells |
Q37978218 | E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease |
Q38821948 | E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271. |
Q36433043 | E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma |
Q35911411 | Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution |
Q36742425 | Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells |
Q28264546 | Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone |
Q35962339 | Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice. |
Q34375340 | Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment |
Q36843250 | Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology |
Q37641235 | Functional role of endothelial adhesion molecules in the early stages of brain metastasis. |
Q51803913 | G-CSF induces E-selectin ligand expression on human myeloid cells. |
Q41657642 | Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells |
Q35850785 | Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration |
Q37958726 | Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation |
Q34026756 | Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses |
Q28251644 | Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration |
Q27027997 | Glycotherapy: new advances inspire a reemergence of glycans in medicine |
Q36205161 | HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions |
Q42043933 | Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. |
Q35256009 | Hematopoietic stem and progenitor cell trafficking |
Q35848474 | Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. |
Q40725605 | Homing and clonogenic outgrowth of CD34(+) peripheral blood stem cells: a role for L-selectin? |
Q38838173 | Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series |
Q35513889 | IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction |
Q24546102 | Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells |
Q35197856 | In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage |
Q38349644 | In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands |
Q33779592 | Induction of apoptosis in glioma cells requires cell-to-cell contact with human umbilical cord blood stem cells |
Q91683057 | Inherited thrombocytopenia associated with mutation of UDP-galactose-4-epimerase (GALE) |
Q44364192 | Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection |
Q36058024 | Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers |
Q30300775 | Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells |
Q43172703 | MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization |
Q37385307 | MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myeloma |
Q28274894 | Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells |
Q30399793 | Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCα-p38-SP-1 pathway |
Q90407798 | Microfluidics-based super-resolution microscopy enables nanoscopic characterization of blood stem cell rolling |
Q47309416 | Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells |
Q37949562 | Mobilization of hematopoietic stem and leukemia cells |
Q38014665 | Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells |
Q38164164 | Molecular signatures of chronic myeloid leukemia stem cells |
Q58761454 | Multiple Roles of Glycans in Hematological Malignancies |
Q34771689 | Murine Lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro |
Q34028119 | NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion |
Q89777786 | Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44 |
Q64061358 | Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia |
Q36403763 | Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size |
Q36980012 | Overlapping roles for endothelial selectins in murine hematopoietic stem/progenitor cell homing to bone marrow |
Q30453100 | P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow |
Q28243799 | PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow |
Q35065252 | Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation. |
Q34839368 | Physiological contribution of CD44 as a ligand for E-Selectin during inflammatory T-cell recruitment. |
Q24653465 | Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells |
Q27313560 | Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay. |
Q40516590 | Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding |
Q37622670 | Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase |
Q35746730 | Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation |
Q36919959 | Role of the retinal vascular endothelial cell in ocular disease |
Q37319042 | SDF-1α-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia |
Q34590239 | Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature |
Q44136529 | Selectins: lectins that initiate cell adhesion under flow |
Q36770572 | Serum amyloid P inhibits granulocyte adhesion |
Q33606887 | Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis |
Q34117459 | Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface |
Q59137901 | Stem cell safe harbor: the hematopoietic stem cell niche in zebrafish |
Q36204478 | Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow |
Q30488087 | Targeting mesenchymal stem cells to activated endothelial cells |
Q24658204 | Targeting selectins and selectin ligands in inflammation and cancer |
Q34475689 | Targeting stem cell niches and trafficking for cardiovascular therapy |
Q27024561 | Targeting tumor-stromal interactions in bone metastasis |
Q34389239 | Terminal sialic acids on CD44 N-glycans can block hyaluronan binding by forming competing intramolecular contacts with arginine sidechains |
Q90043592 | The Bone Marrow Niche - The Tumor Microenvironment That Ensures Leukemia Progression |
Q61449162 | The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering |
Q24628178 | The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives |
Q36028192 | The effect of soluble E-selectin on tumor progression and metastasis. |
Q35172546 | The emerging importance of α-L-fucose in human breast cancer: a review. |
Q38071041 | The hematopoietic stem cell niche--home for friend and foe? |
Q34598130 | The hyaluronan receptor, CD44. |
Q37828460 | The immune system, the skin, and childhood rheumatic disease |
Q39407577 | The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation |
Q58695227 | The micromass formation potential of human adipose-derived stromal cells isolated from different various origins |
Q36420731 | The role of CD44 in fetal and adult hematopoietic stem cell regulation. |
Q38246646 | The role of pericyte detachment in vascular rarefaction |
Q90281838 | The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis |
Q36677300 | The vessel wall and its interactions |
Q90598650 | Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination |
Q35832351 | Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer |
Q85243285 | Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance |
Q41519698 | Western blot analysis of adhesive interactions under fluid shear conditions: the blot rolling assay |
Q54354799 | [Chronic myeloid leukemia stem cells: cross-talk with the niche]. |
Q92739724 | β4GALT1 controls β1 integrin function to govern thrombopoiesis and hematopoietic stem cell homeostasis |
Search more.